Pre and post testing show reversal of memory loss from Alzheimer's disease in 10 patients

(Buck Institute for Research on Aging) A small trial of 10 patients using a personalized systems approach to memory disorders shows an unprecedented reversal of memory loss in those diagnosed with early stage Alzheimers. Pre and post results are based on quantitative MRI and neuropsychological testing. The study, coming from the Buck Institute and UCLA, is based on a protocol dubbed 'metabolic enhancement for neurodegeneration.'